CTRI/2018/03/012284已完成未知
A double blinded, randomized, placebo controlled study to evaluate the efficacy of hair tonic on healthy human subjects. - NI
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Female subjects falling under Grade 2 â?? Grade-4 of hair loss severity grade
- •2)Male subjects falling under Grade 2 to Grade 4 of hair loss severity grade
排除标准
- •1)Subjects who are undergoing hair growth treatment 3 months before screening into the study.
- •2)Subjects who have scalp conditions such as folliculitis, seborrheoic psoriasis of scalp, seborrheoic dermatitis and lichen planopilaris at the time of screening.
研究者
相似试验
已完成
2 期
Effects of perioperative Recombinant Human Erythropoietin administration on proinflammatory cascade following breast cancer surgery.Female subjects with breast cancer stage II/III undergoing a modified radical mastectomyCancer - BreastInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12610000813088niversity Hospital of Ioannina22
进行中（未招募）
不适用
A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid® tree polleEUCTR2006-003067-31-LTETI Pharma GmbH230
进行中（未招募）
不适用
A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid® House dust mites (HDM) in patients suf-fering from moderate to severe atopic eczema.Moderate to severe atopic eczema with or without rhinitis and/or rhinoconjunctivitis caused by clinical relevant IgE-mediated sensitization against House dust mites (HDM) leading to aggravation of patient’s skin lesions.MedDRA version: 8.1Level: LLTClassification code 10003641Term: Atopic eczemaEUCTR2006-003066-34-DEETI Pharma GmbH
进行中（未招募）
不适用
A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid® tree polleRhinitis and/or rhinoconjunctivitis with or without allergic asthma caused by clinical relevant sensitization against tree pollen.MedDRA version: 8.1Level: LLTClassification code 10039083Term: RhinitisEUCTR2006-003067-31-DEETI Pharma GmbH230
进行中（未招募）
不适用
A study of evaluate the efficacy and safety of investigational product Femildo(TM) in management of sexual dysfunction in womeCTRI/2019/01/016868ADSO Naturals Holdings BV24